Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel versus active symptom control for refractory oe... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
0
Authors
Hugo Ford
17 more
Hugo Ford
•
Ian Chau
15 more
•
Janet Dunn
Published
December 10, 2013
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Medical Education
Show all topics
DOI
10.1016/s1470-2045(13)70549-7
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Medical Education
Show all topics
DOI
10.1016/s1470-2045(13)70549-7
License
CC-BY
Other Formats
PDF
